miR-155 |
↑ M1 macrophages |
C/EBPβ, SHIP1, IL13Rα1, SMAD2/3 |
Reprograms pro-tumoral M2/TAM macrophages to M1 pro-inflammatory macrophages |
Macrophage Polarization |
miR-125b |
↑ M1 macrophages |
IRF4 |
↑ responsiveness to IFNγ ↑ tumor killing |
miR-127 |
↑ in M2 macrophages ↓ by inflammation |
DUSP1 |
↑ M1- and ↓ M2-related genes |
miR-146a |
↑ M2 macrophages |
NOTCH1, INHBA, PPARγ, |
↑ M2 polarization and inflammation ↓ M1 polarization |
miR-223 |
↓ TAM |
IL1β, IL-6 |
↑ M2 polarization |
let-7c |
↑ in M2 macrophages ↓ by inflammation |
C/EBPδ, PAK1 |
↑ M2- and ↓ M1-related genes |
miR-511-3p |
↑ TAM |
ROCK2 |
↓ pro-tumoral gene signature of TAMS and ↓ tumor growth |
Tumor invasion |
miR-155 |
↑ M1 macrophages |
SHIP1 |
↑ anti-tumor immunity. MiR-155 KO myeloid cells induce faster tumor growth |
miR-155 |
↑ MDSC |
SOCS1 |
Required for tumor growth and the generation of CD4+ Treg cells. MiR-155 KO mice are resistant to carcinogenesis |
Immune suppression (MDSC) |
miR-494 |
↑ MDSC |
PTEN |
Regulates cell cycle progression; it induces arrest in G2/M and increased inflammation |
miR-20a |
↑ MDSC |
STAT3 |
↓ MDSC-dependent suppression of CD4+ and CD8+ T cell response |
miR-223 |
↓ MDSC |
MEF2C |
Suppresses differentiation of tumor induced- CD11bGr1+MDSC |
miR-21 |
↑ MDSC |
SHIP1 |
↑ proliferation and survival |
miR-690 |
↑ MDSC |
C/EBPα |
↑ MDSC expansion and proliferation ↓ terminal differentiation |
miR-17-5p |
↑ MDSC |
STAT3 |
↓ MDSC ability to suppress Ag-specific CD4+ and CD8+ T cell response |